These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 7517836

  • 21. Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia.
    Betteridge DJ, Durrington PN, Fairhurst GJ, Jackson G, McEwan MS, McInnes GT, Miller JP, Mir MA, Reckless JP, Rees-Jones DI.
    Am J Med; 1994 Jun 06; 96(6A):45S-54S. PubMed ID: 8017467
    [Abstract] [Full Text] [Related]

  • 22. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan 06; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 23. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 06; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 24. Fluvastatin and niacin in hypercholesterolemia: a preliminary report on gender differences in efficacy.
    Jacobson TA, Jokubaitis LA, Amorosa LF.
    Am J Med; 1994 Jun 06; 96(6A):64S-68S. PubMed ID: 8017469
    [Abstract] [Full Text] [Related]

  • 25. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
    Winkler K, Ablethauser CB, Gimpelewicz C, Bortolini M, Isaacsohn JL.
    Clin Ther; 2007 Sep 06; 29(9):1987-2000. PubMed ID: 18035198
    [Abstract] [Full Text] [Related]

  • 26. Combination therapy with fluvastatin and niacin in hypercholesterolemia: a preliminary report on safety.
    Jacobson TA, Amorosa LF.
    Am J Cardiol; 1994 May 26; 73(14):25D-29D. PubMed ID: 8198020
    [Abstract] [Full Text] [Related]

  • 27. Fluvastatin with and without niacin for hypercholesterolemia.
    Jacobson TA, Chin MM, Fromell GJ, Jokubaitis LA, Amorosa LF.
    Am J Cardiol; 1994 Jul 15; 74(2):149-54. PubMed ID: 8023779
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.
    Akiyama T, Ishii T, Imanishi M, Nishioka T, Matsuura T, Kurita T.
    Transplant Proc; 2001 May 15; 33(3):2115-8. PubMed ID: 11377469
    [No Abstract] [Full Text] [Related]

  • 29. The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia.
    West MS, Herd JA, Ballantyne CM, Pownall HJ, Simpson S, Gould L, Gotto AM.
    Control Clin Trials; 1996 Dec 15; 17(6):550-83. PubMed ID: 8974213
    [Abstract] [Full Text] [Related]

  • 30. Effects of fluvastatin on lipid profile and apolipoproteins in Chinese patients with hypercholesterolemia.
    Tomlinson B, Mak TW, Tsui JY, Woo J, Shek CC, Critchley JA, Masarei JR.
    Am J Cardiol; 1995 Jul 13; 76(2):136A-139A. PubMed ID: 7604789
    [Abstract] [Full Text] [Related]

  • 31. Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.
    Hagen E, Istad H, Ose L, Bodd E, Eriksen HM, Selvig V, Bard JM, Fruchart JC, Borge M, Wolf MC.
    Eur J Clin Pharmacol; 1994 Jul 13; 46(5):445-9. PubMed ID: 7957541
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
    Insull W, Black D, Dujovne C, Hosking JD, Hunninghake D, Keilson L, Knopp R, McKenney J, Stein E, Troendle AJ.
    Arch Intern Med; 1994 Nov 14; 154(21):2449-55. PubMed ID: 7979841
    [Abstract] [Full Text] [Related]

  • 33. Risk factors for cardiovascular events in Japanese patients treated with fluvastatin from the long-term event monitoring (LEM) study.
    Morishita R, Itakura H, Nakaya N, Yoshida M, Odawara M, Ichihara A, Mizuno K.
    Curr Vasc Pharmacol; 2012 Mar 14; 10(2):178-86. PubMed ID: 21824105
    [Abstract] [Full Text] [Related]

  • 34. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin.
    Lye M, Valacio R, Reckless JP, Ghosh AK, Findlay IN, Ghosh MK, Passmore AP, Fulcher RA.
    Coron Artery Dis; 1998 Mar 14; 9(9):583-90. PubMed ID: 9861520
    [Abstract] [Full Text] [Related]

  • 35. Fluvastatin for lowering cholesterol.
    Med Lett Drugs Ther; 1994 May 27; 36(923):45-6. PubMed ID: 8177137
    [No Abstract] [Full Text] [Related]

  • 36. Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group.
    Farnier M, Dejager S.
    Am J Cardiol; 2000 Jan 01; 85(1):53-7. PubMed ID: 11078237
    [Abstract] [Full Text] [Related]

  • 37. Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.
    Davidson MH.
    Am J Med; 1994 Jun 06; 96(6A):41S-44S. PubMed ID: 8017466
    [Abstract] [Full Text] [Related]

  • 38. Clinical efficacy of fluvastatin in the long-term treatment of familial hypercholesterolemia.
    Koizumi J, Haraki T, Yagi K, Inazu A, Kajinami K, Miyamoto S, Ueda K, Ohta M, Takegoshi T, Takeda M.
    Am J Cardiol; 1995 Jul 13; 76(2):47A-50A. PubMed ID: 7604797
    [Abstract] [Full Text] [Related]

  • 39. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S, Gamez R, Mas R, Goicochea E.
    Int J Tissue React; 2003 Jul 13; 25(3):81-9. PubMed ID: 14756189
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.
    Sasaki S, Nakagawa M, Nakata T, Endo N, Miyao K, Kitamura K, Fukuyama M, Kitani T, Yamada C.
    Cardiology; 1997 Jul 13; 88(2):160-5. PubMed ID: 9096917
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.